Pfizer Inc. of Canada is recalling 1,441 bottles of Neo-Sulfalyte (neomycin/sulfamethazine/electrolyte) bolus, a veterinary medication used for animals. The recall was initiated because the product was found to be 'out of specification' for low neomycin potency, meaning the medication may not contain the intended amount of the active ingredient neomycin. This medication is packaged in 50-bolus bottles and was distributed only in Canada.
The low potency of neomycin in these boluses may result in reduced effectiveness of the treatment for the intended animal health conditions. If the medication does not provide the required dosage, the underlying infection or condition being treated may not be properly managed.
Product return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response